ZIVO Bioscience, Inc.
General ticker "ZIVO" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $61.7M (TTM average)
ZIVO Bioscience, Inc. does not follow the US Stock Market performance with the rate: -25.6%.
Estimated limits based on current volatility of 8.1%: low 9.60$, high 11.28$
Factors to consider:
- Total employees count: 7 (-12.5%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Insufficient funds to continue operations, Economic downturns and volatility, Dependence on key suppliers, Regulatory and compliance, Operational and conduct risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.24$, 29.46$]
- 2025-12-31 to 2026-12-31 estimated range: [4.37$, 17.38$]
Financial Metrics affecting the ZIVO estimates:
- Negative: with PPE of -4.8 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.12 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Negative: Shareholder equity ratio, % of -31.34 <= 18.93
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term ZIVO quotes
Long-term ZIVO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.03MM | $0.16MM |
| Operating Expenses | $8.73MM | $7.29MM | $13.52MM |
| Operating Income | $-8.73MM | $-7.26MM | $-13.36MM |
| Non-Operating Income | $-0.01MM | $-0.51MM | $-0.02MM |
| Interest Expense | $0.01MM | $0.51MM | $0.02MM |
| R&D Expense | $2.24MM | $1.38MM | $3.13MM |
| Income(Loss) | $-8.75MM | $-7.78MM | $-13.38MM |
| Profit(Loss)* | $-8.75MM | $-7.78MM | $-13.38MM |
| Stockholders Equity | $-0.01MM | $-2.21MM | $-0.51MM |
| Assets | $2.12MM | $0.56MM | $1.64MM |
| Operating Cash Flow | $-7.10MM | $-5.80MM | $-4.31MM |
| Financing Cash Flow | $0.00MM | $4.28MM | $5.58MM |
| Earnings Per Share** | $-5.58 | $-4.60 | $-3.92 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.